Patents by Inventor Ching-Chuan Liu

Ching-Chuan Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELECTRIC FROTHING DEVICE
    Publication number: 20240074609
    Abstract: An electric frothing device includes a driving unit, a connecting rod, and a frothing unit. The driving unit has a housing, and a drive motor disposed in the housing. The drive motor has a power outputting shaft. The connecting rod is fixed to the power outputting shaft of the drive motor. The frothing unit has a fan fixed to the connecting rod and having blades, and a coil spring disposed with an interval from the blades of the fan.
    Type: Application
    Filed: October 19, 2022
    Publication date: March 7, 2024
    Applicant: KITCHEN MAMA LLC
    Inventors: Shih-Chuan CHUANG, Ching-Hsiu YAO, Mao-Xi LIU
  • Method for treating infection of group A
    Patent number: 10345301
    Abstract: A method for treating infection of group A Streptococcus (GAS) includes grouping a patient infected with GAS into an invasive infected candidate. An antibiotic is then administrated to the invasive infected candidate to treat the infection of GAS. Moreover, the patient is grouped into the invasive infected candidate when a first detected level, determined by ex vivo contacting a first biopsy obtained from the patient with a FSBM recombinant protein having an amino acid sequence set forth as SEQ ID NO: 10, is smaller than 0.6.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: July 9, 2019
    Assignee: I-SHOU UNIVERSITY
    Inventors: Chih-Feng Kuo, Ni-Na Tsao, Ching-Chuan Liu, Tzong-Shiann Ho
  • METHOD FOR TREATING INFECTION OF GROUP A STREPTOCOCCUS
    Publication number: 20190094220
    Abstract: A method for treating infection of group A Streptococcus (GAS) includes grouping a patient infected with GAS into an invasive infected candidate. An antibiotic is then administrated to the invasive infected candidate to treat the infection of GAS. Moreover, the patient is grouped into the invasive infected candidate when a first detected level, determined by ex vivo contacting a first biopsy obtained from the patient with a FSBM recombinant protein having an amino acid sequence set forth as SEQ ID NO: 10, is smaller than 0.6.
    Type: Application
    Filed: November 20, 2017
    Publication date: March 28, 2019
    Inventors: Chih-Feng Kuo, Ni-Na Tsao, Ching-Chuan Liu, Tzong-Shiann Ho